Questions and answers on data requirements when transitioning to low global warming potential (LGWP) propellants in oral pressurised metered dose inhalers

Submitted by Anonymous (not verified) on 3 October 2024 - 15:02

Questions and answers on data requirements when transitioning to low global warming potential (LGWP) propellants in oral pressurised metered dose inhalers

Human medicines European public assessment report (EPAR): Zoledronic acid Mylan, zoledronic acid, Date of authorisation: 23/08/2012, Revision: 16, Status: Authorised

Submitted by Anonymous (not verified) on 3 October 2024 - 12:58

Human medicines European public assessment report (EPAR): Zoledronic acid Mylan, zoledronic acid, Date of authorisation: 23/08/2012, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Striascan, ioflupane (123l), Date of authorisation: 25/06/2019, Revision: 4, Status: Authorised

Submitted by Anonymous (not verified) on 3 October 2024 - 12:56

Human medicines European public assessment report (EPAR): Striascan, ioflupane (123l), Date of authorisation: 25/06/2019, Revision: 4, Status: Authorised

Committee for Orphan Medicinal Products (COMP): 16-18 July 2024, European Medicines Agency, Amsterdam, the Netherlands, from 16 July 2024 to 18 July 2024

Submitted by Anonymous (not verified) on 3 October 2024 - 10:32

Committee for Orphan Medicinal Products (COMP): 16-18 July 2024, European Medicines Agency, Amsterdam, the Netherlands, from 16 July 2024 to 18 July 2024

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness